(COVID-19 Version) Global Biologics and Biosimilars Market Status (2015-2019) and Forecast (2020-2025) by Region, Product Type & End-Use

99S4018412
132 Pages
September 2020
Healthcare

Download Sample Get Discount

Summary

A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine.A biosimilar in this report is a biologic medical product which is copy of an original product that is manufactured by a different company. Biosimilars are officially approved versions of original “innovator” products, and can be manufactured when the original product's patent expires.

The report forecast global Biologics and Biosimilars market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2025 due to coronavirus situation.

The report offers detailed coverage of Biologics and Biosimilars industry and main market trends with impact of coronavirus. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Biologics and Biosimilars by geography. The report splits the market size, by volume and value, on the basis of application type and geography.

First, this report covers the present status and the future prospects of the global Biologics and Biosimilars market for 2015-2024.

And in this report, we analyze global market from 5 geographies: Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia], Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland], North America[United States, Canada, Mexico], Middle East & Africa[GCC, North Africa, South Africa], South America[Brazil, Argentina, Columbia, Chile, Peru].

At the same time, we classify Biologics and Biosimilars according to the type, application by geography. More importantly, the report includes major countries market based on the type and application.

Finally, the report provides detailed profile and data information analysis of leading Biologics and Biosimilars company.

Key Content of Chapters as follows (Including and can be customized) :

Part 1:

Market Overview, Development, and Segment by Type, Application & Region

Part 2:

Company information, Sales, Cost, Margin etc.

Part 3:

Global Market by company, Type, Application & Geography

Part 4:

Asia-Pacific Market by Type, Application & Geography

Part 5:

Europe Market by Type, Application & Geography

Part 6:

North America Market by Type, Application & Geography

Part 7:

South America Market by Type, Application & Geography

Part 8:

Middle East & Africa Market by Type, Application & Geography

Part 9:

Market Features

Part 10:

Investment Opportunity

Part 11:

Conclusion

Market Segment as follows:

By Region

Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia]

Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]

North America[United States, Canada, Mexico]

Middle East & Africa[GCC, North Africa, South Africa]

South America[Brazil, Argentina, Columbia, Chile, Peru]

Key Companies

NatureWorks

Braskem

BASF

Arkema

DuPont

Novamont

Corbion

Metabolix

PSM

PolyOne

Biome Bioplastics

Biomer

FKuR

Trellis Bioplastics

Kingfa

Cardia Bioplastics

Grabio

MHG

Myriant

Mitsubishi

Zhejiang Hisun Biomaterials

Market by Type

Bio-PET

PHA

Bio-PE

Starch Blends

PLA

Others

Market by Application

Packing Industry

Automotive Industry

Bottles manufacturing

Others

Table of Contents

Part 1 Market Overview

1.1 Market Definition

1.2 Market Development

1.2.1 Current Situation

1.2.2 Aspects of COVID-19 Impact

1.3 By Type

Table Type of Biologics and Biosimilars

Figure Global Biologics and Biosimilars Market Share by Type in 2019

1.4 By Application

Table Application of Biologics and Biosimilars

Figure Global Biologics and Biosimilars Market Share by Application in 2019

1.5 By Region

Figure Global Biologics and Biosimilars Market Share by Region in 2019

Figure Asia Biologics and Biosimilars Market Share by Region in 2019

Part 2 Key Companies

2.1 NatureWorks

2.1.1 Company Profile

Table NatureWorks Overview List

2.1.2 Products & Services Overview

2.1.3 Sales Data List

Table Biologics and Biosimilars Business Operation of NatureWorks (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

2.2 Braskem

2.3 BASF

2.4 Arkema

2.5 DuPont

2.6 Novamont

2.7 Corbion

2.8 Metabolix

2.9 PSM

2.10 PolyOne

2.11 Biome Bioplastics

2.12 Biomer

2.13 FKuR

2.14 Trellis Bioplastics

2.15 Kingfa

2.16 Cardia Bioplastics

2.17 Grabio

2.18 MHG

2.19 Myriant

2.20 Mitsubishi

2.21 Zhejiang Hisun Biomaterials

Part 3 Global Market Status and Future Forecast

3.1 Global Market by Region

Table Global Biologics and Biosimilars Market by Region, 2015-2019 (Million USD)

Figure Global Biologics and Biosimilars Market Share by Region in 2019 (Million USD)

3.2 Global Market by Company

Table Global Biologics and Biosimilars Market by Company, 2015-2019 (Million USD)

Figure Global Biologics and Biosimilars Market Share by Company in 2019 (Million USD)

3.3 Global Market by Type

Table Global Biologics and Biosimilars Market by Type, 2015-2019 (Million USD)

Figure Global Biologics and Biosimilars Market Share by Type in 2019 (Million USD)

3.4 Global Market by Application

Table Global Biologics and Biosimilars Market by Application, 2015-2019 (Million USD)

Figure Global Biologics and Biosimilars Market Share by Application in 2019 (Million USD)

3.5 Global Market by Forecast

Figure Global Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)

Part 4 Asia-Pacific Market Status and Future Forecast

4.1 Asia-Pacific Market by Type

Table Asia-Pacific Biologics and Biosimilars Market by Type, 2015-2019 (Million USD)

Figure Asia-Pacific Biologics and Biosimilars Market Share by Type in 2019 (Million USD)

4.2 Asia-Pacific Market by Application

Table Asia-Pacific Biologics and Biosimilars Market by Application, 2015-2019 (Million USD)

Figure Asia-Pacific Biologics and Biosimilars Market Share by Application in 2019 (Million USD)

4.3 Asia-Pacific Market by Geography

4.3.1 China Market Status and Future Forecast

Figure China Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)

Figure China Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)

4.3.2 Southeast Asia Market Status and Future Forecast

Figure Southeast Asia Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)

Figure Southeast Asia Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)

4.3.3 India Market Status and Future Forecast

Figure India Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)

Figure India Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)

4.3.4 Japan Market Status and Future Forecast

Figure Japan Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)

Figure Japan Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)

4.3.5 Korea Market Status and Future Forecast

Figure Korea Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)

Figure Korea Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)

4.3.6 Oceania Market Status and Future Forecast

Figure Oceania Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)

Figure Oceania Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)

4.4 Asia-Pacific Market by Forecast

Figure Asia-Pacific Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)

Part 5 Europe Market Status and Future Forecast

5.1 Europe Market by Type

Table Europe Biologics and Biosimilars Market by Type, 2015-2019 (Million USD)

Figure Europe Biologics and Biosimilars Market Share by Type in 2019 (Million USD)

5.2 Europe Market by Application

Table Europe Biologics and Biosimilars Market by Application, 2015-2019 (Million USD)

Figure Europe Biologics and Biosimilars Market Share by Application in 2019 (Million USD)

5.3 Europe Market by Geography

5.3.1 Germany Market Status and Future Forecast

Figure Germany Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)

Figure Germany Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)

5.3.2 UK Market Status and Future Forecast

Figure UK Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)

Figure UK Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)

5.3.3 France Market Status and Future Forecast

Figure France Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)

Figure France Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)

5.3.4 Italy Market Status and Future Forecast

Figure Italy Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)

Figure Italy Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)

5.3.5 Russia Market Status and Future Forecast

Figure Russia Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)

Figure Russia Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)

5.3.6 Spain Market Status and Future Forecast

Figure Spain Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)

Figure Spain Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)

5.3.6 Netherlands Market Status and Future Forecast

Figure Netherlands Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)

Figure Netherlands Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)

5.3.7 Turkey Market Status and Future Forecast

Figure Turkey Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)

Figure Turkey Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)

5.3.6 Switzerland Market Status and Future Forecast

Figure Switzerland Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)

Figure Switzerland Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)

5.4 Europe Market by Forecast

Figure Europe Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)

Part 6 North America Market Status and Future Forecast

6.1 North America Market by Type

Table North America Biologics and Biosimilars Market by Type, 2015-2019 (Million USD)

Figure North America Biologics and Biosimilars Market Share by Type in 2019 (Million USD)

6.2 North America Market by Application

Table North America Biologics and Biosimilars Market by Application, 2015-2019 (Million USD)

Figure North America Biologics and Biosimilars Market Share by Application in 2019 (Million USD)

6.3 North America Market by Geography

6.3.1 United States Market Status and Future Forecast

Figure United States Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)

Figure United States Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)

6.3.2 Canada Market Status and Future Forecast

Figure Canada Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)

Figure Canada Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)

6.3.3 Mexico Market Status and Future Forecast

Figure Mexico Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)

Figure Mexico Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)

6.4 North America Market by Forecast

Figure North America Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)

Part 7 South America Market Status and Future Forecast

7.1 South America Market by Type

Table South America Biologics and Biosimilars Market by Type, 2015-2019 (Million USD)

Figure South America Biologics and Biosimilars Market Share by Type in 2019 (Million USD)

7.2 South America Market by Application

Table South America Biologics and Biosimilars Market by Application, 2015-2019 (Million USD)

Figure South America Biologics and Biosimilars Market Share by Application in 2019 (Million USD)

7.3 South America Market by Geography

7.3.1 Brazil Market Status and Future Forecast

Figure Brazil Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)

Figure Brazil Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)

7.3.2 Argentina Market Status and Future Forecast

Figure Argentina Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)

Figure Argentina Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)

7.3.3 Columbia Market Status and Future Forecast

Figure Columbia Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)

Figure Columbia Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)

7.3.4 Chile Market Status and Future Forecast

Figure Chile Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)

Figure Chile Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)

7.3.5 Peru Market Status and Future Forecast

Figure Peru Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)

Figure Peru Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)

7.4 South America Market by Forecast

Figure South America Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)

Part 8 Middle East & Africa Market Status and Future Forecast

8.1 Middle East & Africa Market by Type

Table Middle East & Africa Biologics and Biosimilars Market by Type, 2015-2019 (Million USD)

Figure Middle East & Africa Biologics and Biosimilars Market Share by Type in 2019 (Million USD)

8.2 Middle East & Africa Market by Application

Table Middle East & Africa Biologics and Biosimilars Market by Application, 2015-2019 (Million USD)

Figure Middle East & Africa Biologics and Biosimilars Market Share by Application in 2019 (Million USD)

8.3 Middle East & Africa Market by Geography

8.3.1 GCC Market Status and Future Forecast

Figure GCC Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)

Figure GCC Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)

8.3.2 North Africa Market Status and Future Forecast

Figure North Africa Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)

Figure North Africa Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)

8.3.3 South Africa Market Status and Future Forecast

Figure South Africa Biologics and Biosimilars Market Market Status, 2015-2019 (Million USD)

Figure South Africa Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)

8.4 Middle East & Africa Market by Forecast

Figure Middle East & Africa Biologics and Biosimilars Market Forecast, 2020-2025 (Million USD)

Part 9 Market Features

9.1 Product Features

9.2 Price Features

9.3 Channel Features

9.4 Purchasing Features

Part 10 Investment Opportunity

10.1 Regional Investment Opportunity

10.2 Industry Investment Opportunity

PART 11 Coronavirus Impact

11.1 Impact on Industry Upstream

11.2 Impact on Industry Downstream

11.3 Impact on Industry Channels

11.4 Impact on Industry Competition

11.5 Impact on Industry Obtain Employment

Part 12 Conclusion

List of Table

Table Type of Biologics and Biosimilars

Table Application of Biologics and Biosimilars

Table NatureWorks Overview List

Table Biologics and Biosimilars Business Operation of NatureWorks (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Life & Medical Business Operation of Braskem (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Business Operation of BASF (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Business Operation of Arkema (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table xxx Business Operation of DuPont (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table xx% Business Operation of Novamont (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table 19 Business Operation of Corbion (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table 4 Business Operation of Metabolix (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table 0 Business Operation of PSM (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table 5 Business Operation of PolyOne (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table 2230 Business Operation of Biome Bioplastics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table 2680 Business Operation of Biomer (Sales Revenue, Cost, Gross Margin)

Table 3480 Business Operation of FKuR (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table 112 Business Operation of Trellis Bioplastics (Sales Revenue, Cost, Gross Margin)

Table Business Operation of Kingfa (Sales Revenue, Cost, Gross Margin)

Table A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine.A biosimilar in this report is a biologic medical product which is copy of an original product that is manufactured by a different company. Biosimilars are officially approved versions of original “innovator” products, and can be manufactured when the original product's patent expires. Business Operation of Cardia Bioplastics (Sales Revenue, Cost, Gross Margin)

Table Business Operation of Grabio (Sales Revenue, Cost, Gross Margin)

Table Business Operation of MHG (Sales Revenue, Cost, Gross Margin)

Table Business Operation of Myriant (Sales Revenue, Cost, Gross Margin)

Table Business Operation of Mitsubishi (Sales Revenue, Cost, Gross Margin)

Table Business Operation of Zhejiang Hisun Biomaterials (Sales Revenue, Cost, Gross Margin)